CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue

MT Newswires Live2024-08-26

CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) attributable profit rose 28% to 2.40 billion yuan in the first half from 1.88 billion ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2462495902?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-26 15:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2462495902","market":"us","top_or_hot":-1,"title":"CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue","media":"MT Newswires Live","content":"<div>\n<p>CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) attributable profit rose 28% to 2.40 billion yuan in the first half from 1.88 billion ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Sanjiu's H1 Profit Jumps 28% on Higher Revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-26 15:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) attributable profit rose 28% to 2.40 billion yuan in the first half from 1.88 billion ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2462495902","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2462495902","pubTimestamp":1724656518,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue China Resources Sanjiu Medical & Pharmaceutical's ","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","SHE":"SPDR MSCI USA Gender Diversity Index ETF","BK0010":"央企","BK0028":"国家队","CR":"crane","03320":"华润医药","BK4588":"碎股","BK0188":"融资融券","BK4526":"热门中概股","BK1570":"华润系","BK0185":"二线龙头","BK0239":"医药制造","BK1191":"制药","HKD":"尚乘数科","BK0175":"白马股","BK0183":"MSCI概念","BK0196":"行业龙头","BK0012":"证金概念","000999":"华润三九","BK4023":"应用软件","BK0060":"抗癌","BK4161":"工业机械"},"translate_title":"华润三九上半年利润因收入增加而增长28%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1,"SHE":1,"HKD":1,"CR":1,"000999":1},"content_text":"CR Sanjiu's H1 Profit Jumps 28% on Higher Revenue China Resources Sanjiu Medical & Pharmaceutical's (SHE:000999) attributable profit rose 28% to 2.40 billion yuan in the first half from 1.88 billion yuan in the year-ago period.Earnings per share at the drug company increased 27% to 1.87 yuan from 1.47 yuan in the previous year, according to a Friday filing by parent China Resources Pharmaceutical (HKG:3320) with the Hong Kong Stock Exchange.Revenue grew 7.3% to 14.11 billion yuan from 13.15 billion yuan a year earlier.CR Sanjiu's shares rose nearly 3% in recent trading.Price (HKD): $43.95, Change: $+1.2, Percent Change: +2.86%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2462495902"}